CILOA SAS One line pitch: An exosome-based breakthrough technology to develop a new generation of safe, affordable and efficient vaccines responding to any future pandemic virus threats. Market Analysis: - Biovision - Document - PDFSEARCH.IO

First Page	Meta Content
	CILOA SAS One line pitch: An exosome-based breakthrough technology to develop a new generation of safe, affordable and efficient vaccines responding to any future pandemic virus threats. Market Analysis: Add to Reading List Document Date: 2015-03-26 10:58:32 Open Document File Size: 209,75 KB Share Result on Facebook Country France / / Currency EUR / USD / / / Facility Montpellier University / / IndustryTerm exosome technology / pharmaceutical / exosome-based breakthrough technology / subsequent applications / / MedicalCondition burn / Dengue / infections / / Organization Montpellier University / / Person Robert Mamoun / Maurice Mamoun / Bernadette Trentin-Mamoun / Philippe Coralie / / / Position CEO / Administrative Officer / / Technology Ciloa technology / Ciloa exosome technology / / URL www.ciloa.fr / / SocialTag Vaccines Vaccination Microbiology Virology Global Vaccines Exosome Virus MedImmune Dengue fever Biology

CILOA SAS One line pitch: An exosome-based breakthrough technology to develop a new generation of safe, affordable and efficient vaccines responding to any future pandemic virus threats. Market Analysis:Add to Reading List